-
Licensed from Japan Tobacco in 2004, JTT-705 is trailing torcetrapib by at least two years.
FORBES: Magazine Article
-
Moreover, there is still a significant chance that neither torcetrapib nor Roche's JTT-705 will prove effective.
FORBES: Magazine Article
-
The Pfizer drug's closest competitor is Roche's pill, known only by the code numbers JTT-705 and R1658.
FORBES: Magazine Article